Acesso livre
Acesso livre

Interesse Geral

Perspectiva | Lições de vida após uma carreira médica na terapia intensiva.

10 Nov, 2021 | 12:33h

Life lessons after a career in intensive care medicine – Intensive Care Medicine

 

Comentário no Twitter

 

Podemos ter certeza de que houve mais de 5 milhões de mortes por Covid no mundo – “Estimar fatalidades ‘em excesso’, um método de análise mais robusto, mostra que a pandemia custou de 10 milhões a 19 milhões de vidas.”

9 Nov, 2021 | 12:21h

We can be confident there have been far more than 5 million global Covid deaths – The Guardian

Conteúdos relacionados:

Global Covid-19 deaths surpass five million.

Effects of the Covid-19 pandemic on life expectancy and premature mortality in 2020 – this time series analysis showed there were more than 28 million excess years of life lost in 2020 in 31 countries.

Under-reporting of deaths limits our understanding of true burden of covid-19.

Study shows COVID-19 has caused the biggest decrease in life expectancy since World War II.

Just how do deaths due to COVID-19 stack up?

Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset.

Exploring the gap between excess mortality and COVID-19 deaths in 67 countries.

Report: Three new estimates of India’s all-cause excess mortality during the COVID-19 Pandemic – pandemic death toll estimated to be between 3.4 million and 4.9 million excess deaths.

COVID-19 has caused 6.9 million deaths globally, more than double what official reports show

Sprays nasais, adesivos livres de agulhas, imunidade duradoura: a próxima geração de vacinas contra COVID.

9 Nov, 2021 | 12:18h

Nose sprays, needle-free patches, durable immunity: towards the next generation of COVID vaccines – The Conversation

 

Nem todas as ondas de Covid são parecidas. Uma análise do aumento da variante Delta.

9 Nov, 2021 | 12:17h

Not all Covid waves look the same. Here’s a snapshot of the Delta surge – STAT

 

Comentário no Twitter

 

Ações para transformar os métodos da USPSTF visando a mitigar o racismo sistêmico nos serviços médicos preventivos.

9 Nov, 2021 | 12:16h

Actions to Transform US Preventive Services Task Force Methods to Mitigate Systemic Racism in Clinical Preventive Services – JAMA

Ver também: Addressing Racism in Preventive Services: Methods Report to Support the US Preventive Services Task Force – JAMA

Comentário: USPSTF Proposes Strategies to Mitigate Racism in Preventive Care – HealthDay

Perspectiva | O motivo de as práticas de autoria em revistas científicas não fazerem sentido.

9 Nov, 2021 | 12:03h

Why scientific journal authorship practices make no sense et al. – Science

Conteúdos relacionados:

Consensus statement on measures to promote equitable authorship in the publication of research from international partnerships.

Editorial: Authorship and Publication Matters: Credit and Credibility.

Opinion: No More First Authors, no More Last Authors

The authorship rows that sour scientific collaborations.

Comunicado de imprensa – ainda não publicado] Estudo randomizado | Novo antiviral oral da Pfizer, candidato a tratamento da Covid-19, reduziu o risco de internação ou morte em 89% em análise interina da fase 2/3 do estudo EPIC-HR.

8 Nov, 2021 | 12:47h

Pfizer’s novel Covid-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR Study

Comentários:

Expert reaction to press release from Pfizer giving interim analysis of their Phase 2/3 EPIC-HR study of PAXLOVID™ in non-hospitalized high-risk adults with COVID-19 – Science Media Centre

Pfizer’s Good News Is the World’s Good News – Science

Experimental Pfizer pill prevents Covid hospitalizations and deaths – STAT

Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% – Health Policy Watch

Pfizer reports good results against severe COVID-19 for its antiviral pill – CIDRAP

Covid: Pfizer says antiviral pill 89% effective in high-risk cases – BBC

Pfizer says COVID-19 pill cut hospital, death risk by 90% – Associated Press

Pfizer’s COVID-19 pill treatment reduces risk of being hospitalized or dying by 89%, company says – ABC News

 

Comentário no Twitter (fio – clique para saber mais)

 

[Ainda não publicado] Farmacêutica Sinovac afirma que sua vacina contra Covid-19 é segura para crianças e mesmo bebês a partir dos 6 meses de vida.

8 Nov, 2021 | 12:45h

Chinese drug firm Sinovac says Covid-19 vaccine safe for children, babies as young as six months old; submits data to Hong Kong government – South China Morning Post

Conteúdos relacionados:

Randomized phase 1/2 trial: Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in children and adolescents aged 3–17 years.

Phase 1/2 RCT: CoronaVac is well tolerated and safe and induces strong humoral responses in children and adolescents aged 3–17 years.

Ponto de vista | Vacinas contra COVID-19 na pediatria: o que pais, médicos e formadores de políticas públicas precisam saber.

8 Nov, 2021 | 12:43h

Pediatric COVID-19 Vaccines: What Parents, Practitioners, and Policy Makers Need to Know – JAMA

Ponto de vista | Crianças e COVID-19 nas escolas.

8 Nov, 2021 | 12:38h

Children and COVID-19 in schools – Science

Conteúdos relacionados:

Instead of quarantine for Covid-exposed students, some schools are trying test-to-stay.

Cluster RCT: Daily contact testing of school-based contacts was non-inferior to self-isolation for control of COVID-19 transmission.

Kids are losing school days to quarantines. Here’s a way to keep them in classrooms – “Test-to-stay could dramatically reduce close contact quarantines”.

Opinion | Data from routine Covid testing can help schools stay open this year.

CDC Report: Schools without mask requirements were more likely to have Covid-19 outbreaks.

Perspective | Schools have begun mass testing for COVID-19. But hurdles and uncertainties remain.

COVID and schools: the evidence for reopening safely.

COVID studies note online learning stress, fewer cases in schools with protocols

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.